2 studies found for:    18786258 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
Condition: Symptomatic Waldenstroms Macroglobulinaemia
Intervention: Drug: Belimumab
2 Completed Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: belimumab;   Biological: Placebo

Indicates status has not been verified in more than two years